IR-Med(OTC) IRME

Current Price$0.00

Market Cap$204.50K

Since IPO (2009)-100%

5 Year-100%

1 Year-92%

1 Month-70%

IR-Med last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-24

IR-Med stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+90.91%	USD 0.00	2026-07-14
1 month	-70%	USD 0.01	2026-05-26
3 month	-70%	USD 0.01	2026-04-08
Year to date	-93%	USD 0.03	2025-12-30
1 year	-91.55%	USD 0.02	2025-07-24
3 year	-99.8%	USD 1.05	2023-07-25
5 year	-99.93%	USD 3.00	2021-07-23
Since inception	-100%	USD 3,205,128.21	2009-05-18

IR-Med Financials at a Glance

Market Cap

$204.50K

Revenue (TTM)

$26.00K

Net Income (TTM)

-$2.35M

EPS (TTM)

-$0.03

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

-0.33 (Low)

Dividend

$0.00

Beta (Volatility)

-0.33 (Low)

Price

$0.00

Volume

2,100

Open

$0.00

Price

$0.00

Volume

2,100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

-0.33 (Low)

Price

$0.00

Volume

2,100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Sep 2, 2026

IRME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About IR-Med

IR-Med Inc. is an emerging medical technology firm focused on developing advanced diagnostic and medical solutions. The company leverages a platform that integrates infra-red light spectroscopy with artificial intelligence to enhance patient care.

Products and Services

PressureSafe: A handheld device for early detection of pressure-induced tissue damage
Nobiotics: An innovative otoscope for diagnosing middle ear infections in children
Advanced diagnostic solutions utilizing AI and infrared technology

Growth Outlook

Strong potential in the medical device market, projected to grow significantly
Innovative product pipeline addressing critical healthcare needs
Focus on expanding market presence and strategic partnerships

Financial Highlights

Recent quarterly net income of -$701,000, reflecting ongoing investment in R&D
Trailing twelve months revenue of $26,000, indicating early-stage product sales
Cash and cash equivalents increased to $63,000 in Q2 2025

IR-Med Inc. operates from Rosh Pina, Israel, and is dedicated to addressing significant healthcare challenges through innovative technology. The company's focus on research and development, combined with a unique product offering, positions it well for future growth in the medical device sector. Despite current financial challenges, the potential for market expansion and product adoption remains strong, making it an intriguing option for investors interested in the healthcare technology space.

AI Generated • Jun 28, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Ran Ziskind

Website

www.ir-medical.com

Headquarters

Rosh Pinna, HZ 1231400, IL

IRME Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

263.69%

Return on Capital

N/A

Return on Assets

-842.29%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$204.50K

Shares Outstanding

97.38M

Volume

2.10K

Avg. Volume

98.419

Financials (TTM)

Gross Profit

$2.00K

Operating Income

-$1.46M

EBITDA

-$1.40M

Operating Cash Flow

-$837.00K

Capital Expenditure

$0.00

Free Cash Flow

-$837.00K

Cash & ST Invst.

$63.00K

Total Debt

$250.00K

IR-Med Performance Analysis

IR-Med annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 0	N/A
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A

IR-Med sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2024-09-30	N/A
Q4	2024-12-31	N/A
Q1	2025-03-31	-100.0%
Q2	2025-06-30	N/A

IR-Med annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.06	N/A
2022	2022-12-31	USD -0.07	18.8%
2023	2023-12-31	USD -0.07	1.0%
2024	2024-12-31	USD -0.03	-61.8%

IR-Med sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2024-09-30	-63.5%
Q4	2024-12-31	54.1%
Q1	2025-03-31	-176.9%
Q2	2025-06-30	12.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$4.00K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

$204.50K

N/A

Market Cap/Employee

$68.17K

N/A

Employees

N/A

Net Income

-$701.00K

-91.5%

EBITDA

-$282.00K

+20.3%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

$63.00K

-91.6%

Total Debt

$250.00K

+59.2%

Accounts Receivable

$27.00K

-25.0%

Inventory

$0.00

N/A

Long Term Debt

$26.00K

-83.4%

Short Term Debt

$224.00K

N/A

Return on Assets

-8.42%

N/A

Return on Invested Capital

89.98%

N/A

Free Cash Flow

-$71.00K

+80.9%

Operating Cash Flow

-$71.00K

+80.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SIGYSigyn Therapeutics, Inc.

SIGYSigyn Therapeutics, Inc.$0.03+0.00%

LMLLFPharmadrug Inc.

LMLLFPharmadrug Inc.$0.01+0.00%

SLDXStella Diagnostics Inc.

SLDXStella Diagnostics Inc.$0.01+0.00%

LLBOLifeline Biotechnologies, Inc.

LLBOLifeline Biotechnologies, Inc.$0.00+0.00%

TBRIFTherma Bright Inc.

TBRIFTherma Bright Inc.$0.04+0.00%

RMSLREMSleep Holdings, Inc.

RMSLREMSleep Holdings, Inc.$0.00+25.65%

RVVTFRevive Therapeutics Ltd.

RVVTFRevive Therapeutics Ltd.$0.02-7.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

NUNu Holdings

NUNu Holdings$14.09-0.01%

TAT&T

TAT&T$24.13+0.05%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

Questions About IRME

What is the current price of IR-Med?

IR-Med is trading at $0.00 per share.

What is the 52-week range for IR-Med?

Over the past 52 weeks, IR-Med has traded between $0.00 and $0.05.

How much debt does IR-Med have?

As of the most recent reporting period, IR-Med reported total debt of $250.00K.

How much cash does IR-Med have on hand?

IR-Med reported $63.00K in cash and cash equivalents in its most recent financial results.

What is IR-Med’s dividend yield?

IR-Med does not currently have a dividend yield.

IR-Med(OTC) IRME

IR-Med Financials at a Glance

IRME News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About IR-Med

IRME Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

IR-Med Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IRME

What is the current price of IR-Med?

What is the 52-week range for IR-Med?

How much debt does IR-Med have?

How much cash does IR-Med have on hand?

What is IR-Med’s dividend yield?

Premium Investing Services